Therefore, GITR inhibitors and GITR agonists may have interesting effects in several cancers, while Clinicaltrials.gov portal shows no clinical trials on GITR-related drugs in cholangiocarcinoma, pheochromocytoma, testis cancers nor in thymoma. The gene discussed is TNFRSF18; the disease is cholangiocarcinoma.